Allena Pharmaceuticals (ALNA) –
-
Form 25-NSE Allena Pharmaceuticals, Filed by: Nasdaq Stock Market LLC
-
Allena Pharmaceuticals (ALNA) received notice from Nasdaq that its shares will be suspended
-
Form 8-K Allena Pharmaceuticals, For: Sep 06
-
Form 8-K Allena Pharmaceuticals, For: Aug 29
-
Form 8-K Allena Pharmaceuticals, For: Aug 23
-
Form 10-Q Allena Pharmaceuticals, For: Jun 30
-
Allena Pharmaceuticals (ALNA) to Resume Trading at 8:30 a.m.
-
Allena Pharmaceuticals (ALNA) reports clinical and corporate update
-
Form 8-K Allena Pharmaceuticals, For: Aug 11
-
Allena Pharmaceuticals (ALNA) Halted, News Pending
-
Form 8-K Allena Pharmaceuticals, For: Aug 04
-
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease
-
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease
-
Form DEFA14A Allena Pharmaceuticals,
-
Form 8-K Allena Pharmaceuticals, For: Jul 12
-
Form DEFA14A Allena Pharmaceuticals,
-
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split
-
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split
-
Form 8-K Allena Pharmaceuticals, For: Jul 08
-
Form 424B5 Allena Pharmaceuticals,
-
Form 8-K Allena Pharmaceuticals, For: Jul 08
-
Form DEFA14A Allena Pharmaceuticals,
-
Form 8-K Allena Pharmaceuticals, For: Jul 05
-
Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split
-
Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split
-
Form 8-K Allena Pharmaceuticals, For: Jun 27
-
Form S-1 Allena Pharmaceuticals,
-
Form 8-K Allena Pharmaceuticals, For: Jun 15
-
Form DEFA14A Allena Pharmaceuticals,
-
Form DEF 14A Allena Pharmaceuticals, For: Jul 05
-
Form D Allena Pharmaceuticals,
-
Form 10-Q Allena Pharmaceuticals, For: Mar 31
-
Form PRE 14A Allena Pharmaceuticals, For: May 13
-
Form DEFA14A Allena Pharmaceuticals,
-
Form 8-K Allena Pharmaceuticals, For: May 03
-
Form 424B5 Allena Pharmaceuticals,
-
Allena Pharmaceuticals (ALNA) Announces $2.8M Registered Direct Offering
-
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
-
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
-
Form 10-K/A Allena Pharmaceuticals, For: Dec 31
-
Form 10-K Allena Pharmaceuticals, For: Dec 31
-
B.Riley Downgrades Allena Pharmaceuticals (ALNA) to Neutral
-
H.C. Wainwright Downgrades Allena Pharmaceuticals (ALNA) to Neutral
-
UPDATE: Ladenburg Thalmann Downgrades Allena Pharmaceuticals (ALNA) to Neutral
-
Form 8-K Allena Pharmaceuticals, For: Mar 18
-
Form 8-K Allena Pharmaceuticals, For: Feb 24
-
Form SC 13G/A Allena Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
-
Form 4 Allena Pharmaceuticals, For: Feb 01 Filed by: Katz Richard D
-
Form 4 Allena Pharmaceuticals, For: Feb 01 Filed by: BRENNER LOUIS MD
-
Form 8-K Allena Pharmaceuticals, For: Jan 28
Back to ALNA Stock Lookup